Aton Ra Partners Regeneron Pharmaceuticals, Inc. Transaction History

Aton Ra Partners

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $977,277 - $1.15 Million	-2,067 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $178,245 - $218,731	399 Added 23.92%	2,067 $978,000
Q4 2020 Feb 19, 2021	BUY	$478.3 - $607.98 $797,804 - $1.01 Million	1,668 New	1,668 $806,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.